Lucentis Injection
Marketer
Novartis India Ltd
Salt Composition
Ranibizumab (0.5mg)
Overview Lucentis Injection
Ranibizumab injection treats diabetic retinopathy, age-related macular degeneration, and macular edema. By inhibiting abnormal blood vessel growth and leakage in the eye, it helps prevent vision impairment. Administration is strictly by an ophthalmologist via intravitreal injection; self-injection is dangerous and prohibited. Potential side effects include conjunctival bleeding, ocular pain, floaters, elevated intraocular pressure, and eye irritation. Persistent side effects or any concerning symptoms warrant immediate medical attention. Post-injection driving is discouraged due to potential temporary visual disturbances.
Uses of Lucentis Injection
Retinal complications of diabetes | Neovascular age-related macular degeneration | Macular swelling from retinal vein blockage
Major Benefits of Lucentis Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Lucentis Injection:
- Conjunctival hemorrhage
- Eye pain
- Increased intraocular pressure
- Foreign body sensation in eyes
- Blurred vision
- Nausea
- Dry eye
- Eye itching
- Cataract
- Vitreous floaters
- Vitreous detachment
- Intraocular inflammation
- Eye irritation
- Increased lacrimation
- Eyelid inflammation
- Ocular hyperemia
- Retinal disorder
- Maculopathy
- Eye discomfort
- Posterior capsule opacification
- Injection site hemorrhage
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Anemia (low number of red blood cells)
- Joint pain
- Renal failure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Gastro-esophageal reflux disease
- Hypercholesterolemia (high cholesterol)
- Bronchitis (inflammation of the airways)
How to use Lucentis Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Lucentis Injection works:
Lucentis injection is an anti-VEGF therapy that inhibits vascular endothelial growth factor, thereby preventing the formation and permeability of aberrant ocular blood vessels, which can lead to visual impairment.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Lucentis Injection lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Lucentis injections during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. Your physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Lucentis Injection while breastfeeding is likely safe. Available data from humans indicates minimal risk to the infant.
DrivingUNSAFE
Following a Lucentis injection, temporary blurred vision may occur. Refrain from driving until your vision returns to normal.
KidneySAFE IF PRESCRIBED
For individuals with kidney disease, Lucentis injections are likely safe. Current evidence indicates dose modification may not be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Lucentis Injection in patients with liver conditions appears to present minimal risk. Available evidence indicates dose modification may be unnecessary for this patient population. Physician consultation is recommended.
What if you forget to take Lucentis Injection :
Omit a Lucentis Injection dose? Seek your physician's advice.
Facts to Know About Lucentis Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
| Behavioral Class | Anti-VEGF therapy for age-related macular degeneration |
3,018 People bought this recently